Natural Language Processing (NLP) in Healthcare and Life Sciences Market Report 2026

The natural language processing (nlp) in healthcare and life sciences market size has grown exponentially in recent years. It will grow from $3.7 billion in 2025 to $4.59 billion in 2026 at a compound annual growth rate (CAGR) of 23.9%. The growth in the historic period can be attributed to digital health record adoption, healthcare data growth, early clinical analytics tools, regulatory reporting needs, rising healthcare costs.

The natural language processing (nlp) in healthcare and life sciences market size is expected to see exponential growth in the next few years. It will grow to $10.99 billion in 2030 at a compound annual growth rate (CAGR) of 24.4%. The growth in the forecast period can be attributed to AI integration in clinical workflows, precision medicine adoption, healthcare automation demand, cloud based healthcare platforms, shortage of medical professionals. Major trends in the forecast period include clinical text analytics, automated medical coding, AI driven drug discovery, virtual health assistants, real time clinical decision support.

The growing demand for personalized medicine is fueling the expansion of NLP in the healthcare and life sciences market. Personalized medicine customizes medical treatment according to an individual’s unique characteristics, including genetic profile or lifestyle, to achieve more precise and effective healthcare outcomes. Utilizing Natural Language Processing (NLP) in this sector enables the extraction and analysis of large volumes of patient data, supporting personalized medicine by providing insights into individualized health profiles and treatment approaches. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based nonprofit, reported that the USFDA approved 16 new personalized treatments for rare disease patients in 2023, a notable rise from six in 2022. Consequently, the increasing demand for personalized medicine is expected to drive NLP growth in the healthcare and life sciences market.

Major companies in the NLP healthcare and life sciences market are focusing on product launches, such as generative AI-powered services, which automatically generate preliminary clinical documentation from patient-clinician interactions. A generative AI-powered service leverages artificial intelligence to autonomously produce content, solutions, or outcomes based on learned patterns and input data. For instance, in July 2023, Amazon Web Services (AWS), a U.S.-based cloud computing provider, launched AWS HealthScribe, a generative AI-powered service that automatically creates clinical documentation. The service combines speech recognition and generative AI to identify speaker roles, classify dialogues, extract medical terms, and generate comprehensive preliminary clinical transcripts, streamlining documentation and enhancing NLP efficiency in healthcare. By delivering HIPAA-compliant automation, AWS HealthScribe reduces documentation time for healthcare professionals while improving workflow efficiency and patient care quality.

In May 2023, Intelligent Medical Objects, a U.S.-based provider of clinical terminology management, data quality, and healthcare data enablement solutions, acquired Melax Technologies, Inc. for an undisclosed amount. Through this acquisition, Intelligent Medical Objects aims to enhance its NLP-driven analytics and business intelligence offerings for healthcare organizations, expanding its market presence in clinical and financial performance optimization. Melax Technologies, a U.S.-based provider of healthcare data analytics and business intelligence services, specializes in leveraging NLP to extract insights from biomedical texts and unstructured clinical information.

Major companies operating in the natural language processing (nlp) in healthcare and life sciences market are Google LLC; Microsoft Corporation; Optum Inc.; Amazon Web Services Inc.; International Business Machines Corporation; 3M Company; IQVIA Holdings Inc.; Cerner Corporation; Inovalon Holdings Inc.; NextGen Healthcare Inc.; Welltok Inc.; HealthFusion Inc.; Syapse Inc.; Apixio Inc.; Infermedica; Health Fidelity Inc.; Linguamatics Ltd.; Dolbey Systems Inc.; Lexalytics Inc.; Clinithink Ltd.; Semedy AG; Zyla Health; Anumana Inc.; Averbis GmbH; Pera Health; Notable Health; Olive AI; Olive Inc.; Epic Systems Corporation.

North America was the largest region in the NLP in healthcare and life sciences market in 2025. The regions covered in the natural language processing (nlp) in healthcare and life sciences market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the natural language processing (nlp) in healthcare and life sciences market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have had a moderate impact on the nlp in healthcare and life sciences market by increasing costs of imported computing hardware and specialized servers. These impacts are more visible in large scale data centers and research institutions across asia pacific and europe. Software and cloud based nlp solutions remain largely insulated from direct tariff effects. Higher tariffs have encouraged cloud migration and software centric deployments. This shift is accelerating scalable and cost efficient healthcare analytics adoption.

The natural language processing (nlp) in healthcare and life sciences market research report is one of a series of new reports that provides natural language processing (nlp) in healthcare and life sciences market statistics, including natural language processing (nlp) in healthcare and life sciences industry global market size, regional shares, competitors with a natural language processing (nlp) in healthcare and life sciences market share, detailed natural language processing (nlp) in healthcare and life sciences market segments, market trends and opportunities, and any further data you may need to thrive in the natural language processing (nlp) in healthcare and life sciences industry. This natural language processing (nlp) in healthcare and life sciences market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Natural Language Processing (NLP) in healthcare and life sciences is a domain of Artificial Intelligence (AI) focused on enabling machines to understand and communicate using human language. This technology is employed to identify data patterns and execute automated tasks within the healthcare and life sciences sectors.

NLP in healthcare and life sciences encompasses various types, including rule-based NLP, statistical NLP, and hybrid NLP. Rule-based NLP, also referred to as rule-based natural language processing, involves processing and comprehending human language through pre-established rules and patterns. The components of NLP include solutions and services catering to both large enterprises and small to midsize enterprises (SMEs). Applications of NLP in this context span sentiment analysis, drug discovery, clinical trial matching, risk and compliance management, dictation and EMR implication, automated registry reporting, AI chatbots and virtual scribe, among others. These applications find utility in sectors such as public health and government agencies, medical devices, healthcare insurance, pharmaceuticals, and more.

The NLP in healthcare and life sciences market consists of revenues earned by entities by providing information extraction, streamline workflows, improve predictive analytics, and clinical decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The NLP in healthcare and life sciences market also includes sales of medical coder and EHRs (electronic health records). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.